These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 4983105)

  • 1. [Extrapyramidal complications of psychopharmacological drugs].
    Vacek J
    Cesk Psychiatr; 1969 Dec; 65(6):414-21. PubMed ID: 4983105
    [No Abstract]   [Full Text] [Related]  

  • 2. [The drug-induced Parkinson's syndrome].
    Pakesch E
    Wien Z Nervenheilkd Grenzgeb; 1966; 23(1):140-6. PubMed ID: 4226879
    [No Abstract]   [Full Text] [Related]  

  • 3. A survey of extrapyramidal manifestations in patients attending an after care clinic of a psychiatric hospital.
    Guttman H; Lehmann HE; Ban TA
    Laval Med; 1970 Apr; 41(4):449-55. PubMed ID: 5515661
    [No Abstract]   [Full Text] [Related]  

  • 4. A survey of extrapyramidal manifestations in the inpatient population of a psychiatric hospital.
    Lehmann HE; Ban TA; Saxena BM
    Laval Med; 1970 Sep; 41(7):909-16. PubMed ID: 5509489
    [No Abstract]   [Full Text] [Related]  

  • 5. [Causes of persisting extrapyramidal hyperkinesis after prolonged administration of major tranquilizers].
    Degkwitz R
    Act Nerv Super (Praha); 1967 Nov; 9(4):389-400. PubMed ID: 5612952
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug-induced extrapyramidal symptoms: their incidence and treatment.
    Sheppard C; Merlis S
    Am J Psychiatry; 1967 Jan; 123(7):886-9. PubMed ID: 6016862
    [No Abstract]   [Full Text] [Related]  

  • 7. Neutralization of extrapyramidal side-effects with Methixene.
    Maller O; Heller S
    Dis Nerv Syst; 1971 Jun; 32(6):409-15. PubMed ID: 5570695
    [No Abstract]   [Full Text] [Related]  

  • 8. [Persistent extrapyramidal syndrome in neuroleptic therapy].
    Hoff H; Hofmann G
    Wien Med Wochenschr; 1967 Jan; 117(1):14-7. PubMed ID: 6031954
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the mode of action and the question of central organic late damages of continuous neuroleptic treatment].
    Haddenbrock S
    Nervenarzt; 1966 May; 37(5):199-203. PubMed ID: 5298253
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study of extrapyramidal manifestations induced by neuroleptics].
    Bordeleau JM; Tétreault L
    Rev Can Biol; 1972; 31():Suppl:247-53. PubMed ID: 4403291
    [No Abstract]   [Full Text] [Related]  

  • 11. [Movement disorders as a concomitant syndrome in the use of psychopharmacological agents].
    von der Mühlen H
    Z Allgemeinmed; 1973 Oct; 49(30):1441-7. PubMed ID: 4768492
    [No Abstract]   [Full Text] [Related]  

  • 12. [Action of amantadine in extrapyramidal syndromes caused by neuroleptics].
    Fanali A; Nardini M; Sorgona F
    Sist Nerv; 1970; 22(5):273-85. PubMed ID: 5514245
    [No Abstract]   [Full Text] [Related]  

  • 13. [Side effects by psychopharmacologic drugs in childhood (author's transl)].
    Rosenmayr F; Groh C
    Padiatr Padol; 1974; 9(2):144-51. PubMed ID: 4823696
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug induced functional disorders of the tongue, pharynx and larynx].
    Bauer H
    Z Laryngol Rhinol Otol; 1967 Mar; 46(3):154-9. PubMed ID: 4870673
    [No Abstract]   [Full Text] [Related]  

  • 15. [Side effects of neuroleptics in compound preparations].
    Schulte PW; Zimmermann H
    Med Klin; 1971 Nov; 66(48):1644-8. PubMed ID: 4400005
    [No Abstract]   [Full Text] [Related]  

  • 16. [Persisting extrapyramidal syndrome following neuroleptic therapy].
    Nehlil J
    Rev Neurol (Paris); 1969 Apr; 120(4):270-1. PubMed ID: 5343622
    [No Abstract]   [Full Text] [Related]  

  • 17. [Progress and limitation of psychopharmacological therapy].
    Hoff H; Hofmann G
    Psychiatr Neurol Med Psychol (Leipz); 1967 Dec; 19(12):441-8. PubMed ID: 6082949
    [No Abstract]   [Full Text] [Related]  

  • 18. [Orolingual dyskinesia caused by prolonged neuroplegic therapy].
    Fenyvesi T
    Orv Hetil; 1968 Sep; 109(39):2149-52. PubMed ID: 5716904
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study on the extrapyramidal system from the standpoint of pharmacology and psychopharmacology].
    Hara S
    Zasshi Tokyo Ika Daigaku; 1969 Jan; 27(1):1-22. PubMed ID: 4978901
    [No Abstract]   [Full Text] [Related]  

  • 20. [l-dopa treatment of Parkinson's syndrome and mechanism of action of neuroleptics].
    Degkwitz R
    Med Klin; 1969 Aug; 64(33):1451-6. PubMed ID: 4896563
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.